SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Sanofi India - Quaterly Results

23 Feb 2022 Evaluate
The revenue slipped marginally during the December 2021 quarter. A decline of about Rs. 6879.00 millions was observed as compared to Rs. 7203.00 millions during the corresponding quarter last year.The Company's Net profit for the December 2021 quarter have declined marginally to Rs. 904.00  millions as against Rs. 1230.00 millions reported during the corresponding quarter ended.The company reported a degrowth in operating Profit to 1435.00 millions from 1832.00 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202112 202012 % Var 202112 202012 % Var 202112 202012 % Var
Sales 6879.00 7203.00 -4.50 29566.00 29019.00 1.88 29566.00 29019.00 1.88
Other Income 163.00 162.00 0.62 744.00 898.00 -17.15 744.00 898.00 -17.15
PBIDT 1435.00 1832.00 -21.67 8369.00 8029.00 4.23 8369.00 8029.00 4.23
Interest 4.00 4.00 0.00 18.00 18.00 0.00 18.00 18.00 0.00
PBDT 1431.00 1906.00 -24.92 13243.00 7594.00 74.39 13243.00 7594.00 74.39
Depreciation 109.00 204.00 -46.57 667.00 822.00 -18.86 667.00 822.00 -18.86
PBT 1322.00 1702.00 -22.33 12576.00 6772.00 85.71 12576.00 6772.00 85.71
TAX 418.00 472.00 -11.44 3132.00 1996.00 56.91 3132.00 1996.00 56.91
Deferred Tax -12.00 5.00 -340.00 -228.00 -114.00 100.00 -228.00 -114.00 100.00
PAT 904.00 1230.00 -26.50 9444.00 4776.00 97.74 9444.00 4776.00 97.74
Equity 230.00 230.00 0.00 230.00 230.00 0.00 230.00 230.00 0.00
PBIDTM(%) 20.86 25.43 -17.98 28.31 27.67 2.31 28.31 27.67 2.31

Sanofi India Share Price

3578.55 18.75 (0.53%)
20-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1668.00
Dr. Reddys Lab 1232.25
Cipla 1228.90
Zydus Lifesciences 936.35
Lupin 2328.60
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×